[
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-1",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#definitiongeneral385441",
    "clean_content": "Definition / general\n\n* Undifferentiated carcinoma of the pancreas with no glandular differentiation and with prominent infiltration by histiocytes and osteoclast-like giant cells* May be found in association with a differentiated component of [pancreatic ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html)"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-2",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#essentialfeatures385442",
    "clean_content": "Essential features\n\n* Undifferentiated carcinoma with atypical neoplastic cells and lacking gland formation* Presence of multinucleated giant cells resembling osteoclasts"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-3",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#terminology385443",
    "clean_content": "Terminology\n\n* Undifferentiated carcinoma with osteoclast-like giant cells (UCOGC, UCOCGC)* Old terminology, not in use: giant cell tumor of the pancreas, osteoclastoma"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-4",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#icdcoding385444",
    "clean_content": "ICD coding\n\n* ICD-O: [8035/3](https://apps.who.int/iris/bitstream/handle/10665/96612/9789241548496_eng.pdf?sequence=1#page=63) - carcinoma with osteoclast-like giant cells* ICD-10: [C25.9](https://www.icd10data.com/ICD10CM/Codes/C00-D49/C15-C26/C25-/C25.9) - malignant neoplasm of pancreas, unspecified"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-5",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#epidemiology385445",
    "clean_content": "Epidemiology\n\n* M:F = 0.9:1 ([Am J Surg Pathol 2016;40:1203](27508975), [J Pathol 2017;243:148](28722124))* Commonly presents in the sixth to seventh decades ([Am J Surg Pathol 2016;40:1203](27508975), [J Pathol 2017;243:148](28722124))* 1.4% of all pancreatic cancers ([Am J Surg Pathol 2016;40:1203](27508975))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-6",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sites",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#sites385446",
    "clean_content": "Sites\n\n* Head of the pancreas (60 - 75% of cases), body / tail (25 - 40%) ([Am J Surg Pathol 2016;40:1203](27508975), [J Pathol 2017;243:148](28722124))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-7",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#pathophysiology385447",
    "clean_content": "Pathophysiology\n\n* Unknown; a role may be played by hemorrhagic / chronic inflammatory foci with recruitment of tumor supporting macrophages within the pancreas or within a pancreatic ductal adenocarcinoma ([Hum Pathol 2018;81:157](30031096))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-8",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#clinicalfeatures385448",
    "clean_content": "Clinical features\n\n* Presenting symptoms include jaundice (tumors in the pancreatic head), abdominal or back pain, weight loss and nausea ([Am J Surg Pathol 2016;40:1203](27508975), [J Pathol 2017;243:148](28722124))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-9",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#diagnosis385449",
    "clean_content": "Diagnosis\n\n* CT scan and MRI are the preferred imaging modalities* Diagnosis is by biopsy or surgical resection (more difficult with cytology but may be possible) ([Cancer Cytopathol 2017;125:563](28371566))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-10",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#radiologydescription385450",
    "clean_content": "Radiology description\n\n* Usually mass lesions with delayed enhancement ([Am J Surg Pathol 2016;40:1203](27508975))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-11",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Radiology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#radiologyimages385451",
    "clean_content": "Radiology images\n\nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc05.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283196/figure/F1/)\n\nUltrasound\n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc06.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283196/figure/F2/)\nâ€ƒ\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc07.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292306/figure/F1/)\n\nCT"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-12",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#prognosticfactors385452",
    "clean_content": "Prognostic factors\n\n* Presence of an associated conventional ductal adenocarcinoma component is associated with a poorer prognosis and is one of the most important prognostic moderators ([Am J Surg Pathol 2016;40:1203](27508975), [J Pathol 2017;243:148](28722124))* PDL1 expression by tumor cells is associated with poor prognosis ([Hum Pathol 2018;81:157](30031096))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-13",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#casereports385453",
    "clean_content": "Case reports\n\n* 54 year old man with a huge (28 cm) mass for which radical resection was possible ([Int Cancer Conf J 2017;6:193](31149501))* 54 year old woman with a large cystic mass in the pancreas ([Int J Clin Exp Pathol 2015;8:11785](26617927))* 61 year old woman with long term survival after surgical resection and chemotherapy ([Case Rep Gastroenterol 2016;10:472](27721735))* 62 year old woman with metastatic disease showing durable response to immunotherapy (tumor with high tumor mutational burden) ([J Natl Compr Canc Netw 2021;19:247](33668025))* 65 year old man with weight loss ([Medicine (Baltimore) 2018;97:e13516](30508980))* 68 year old woman with a prominent invasion of pancreatic ductal tree ([JOP 2011;12:170](21386647))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-14",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#treatment385454",
    "clean_content": "Treatment\n\n* Surgical resection if possible, gemcitabine based chemotherapy ([Case Rep Gastroenterol 2016;10:472](27721735))* Immunotherapy is a novel opportunity to be explored in this type of cancer ([BMC Gastroenterol 2020;20:220](32652936), [J Natl Compr Canc Netw 2021;19:247](33668025))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-15",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#grossdescription385455",
    "clean_content": "Gross description\n\n* Larger than conventional [ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html) ([J Pathol 2017;243:148](28722124))* Brownish (not whitish) and with pushing borders* Frequent cyst formation* Hemorrhage or necrosis is typically present"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-16",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#grossimages385456",
    "clean_content": "Gross images\n\nContributed by Claudio Luchini, M.D., Ph.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini01new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini01new.jpg)\n\nCystic tumor\n\n  \n  \nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc01.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204565/figure/F3/)\n\nHemorrhagic mass\n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticgross1.jpg)](https://journals.lww.com/cancerjournal/_layouts/15/oaks.journals/ImageView.aspx?k=cancerjournal:2015:11040:00187&i=F2-187&year=2015&issue=11040&article=00187&type=Fulltext)\n\nMacrophotograph revealing cystic mass\n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc08.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186749/figure/F2/)\n\nCystic mass with gastric invasion"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-17",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Frozen section description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#frozensectiondescription385457",
    "clean_content": "Frozen section description\n\n* Hypercellular neoplasm with atypical cells* Multinucleated giant cells, although they cannot always be documented in small biopsy sent for frozen section (may be focal component)"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-18",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Frozen section images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#frozensectionimages385458",
    "clean_content": "Frozen section images\n\nContributed by Claudio Luchini, M.D., Ph.D.  \n\n[![Osteoclast-like giant cells and neoplastic cells](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini02new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini02new.jpg)\n\nOsteoclast-like giant cells and neoplastic cells"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-19",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#microscopichistologicdescription385459",
    "clean_content": "Microscopic (histologic) description\n\n* Composed of 3 cell types:\n  + Mononuclear neoplastic cells, sometimes very atypical+ Mononuclear histiocytes (nonneoplastic)+ Multinucleated giant cells (osteoclast-like giant cells) (nonneoplastic)* Foci of hemorrhage and necrosis are very common* Typical involvement of the pancreatic ductal tree, sometimes with a pseudopolypoid growth pattern ([J Pathol 2017;243:148](28722124))* May arise in association with [mucinous cystic neoplasm of the pancreas](https://www.pathologyoutlines.com/topic/pancreasmcn.html) and [intraductal papillary mucinous neoplasm of the pancreas](https://www.pathologyoutlines.com/topic/pancreasipmn.html) ([Am J Surg Pathol 2016;40:1203](27508975), [World J Surg Oncol 2011;9:100](21902830), [Am J Surg Pathol 2015;39:179](25517958))* Osteoid material may be found ([J Pathol 2017;243:148](28722124))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-20",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#microscopichistologicimages385460",
    "clean_content": "Microscopic (histologic) images\n\nContributed by Claudio Luchini, M.D., Ph.D.  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini03new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini03new.jpg)\nâ€ƒ\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini04new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini04new.jpg)\n\nAssociated conventional adenocarcinoma\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini05new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini05new.jpg)\n\nDuctal tree involvement\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini06new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini06new.jpg)\n\nMicrohemorrhagic foci\n\n  \n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini07new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini07new.jpg)\n\nExtensive necrotic hemorrhage\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini08new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini08new.jpg)\n\nCK8/18+\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini09new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini09new.jpg)\n\nFocal CK8/18+\n\n[![](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini10new.jpg)](https://www.pathologyoutlines.com/imgau/pancreasosteoclasticluchini10new.jpg)\n\nCK8/18-"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-21",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#cytologydescription385461",
    "clean_content": "Cytology description\n\n* 3 cell types (osteoclast-like giant cells, neoplastic cells and histiocytes) are present in most cases (~80%)* Cytology has a diagnostic value for this tumor in ~80% of cases ([Cancer Cytopathol 2017;125:563](28371566))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-22",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Cytology images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#cytologyimages385462",
    "clean_content": "Cytology images\n\nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc02.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999083/figure/F1/)\n\nRomanowsky stain\n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc09.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999083/figure/F2/)\n\nPapanicolaou stain"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-23",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Positive stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#positivestains385463",
    "clean_content": "Positive stains\n\n* Neoplastic cells:\n  + [Cytokeratin AE1 / AE3](https://www.pathologyoutlines.com/topic/stainsae1ae3.html), [CK7](https://www.pathologyoutlines.com/topic/stainsck7.html), [CK8/18](https://www.pathologyoutlines.com/topic/CK818.html) are usually positive but may be totally negative+ [p53](https://www.pathologyoutlines.com/topic/stainsp53.html) in > 50% of cases+ [Ki67](https://www.pathologyoutlines.com/topic/stainski67.html) high proliferation index* Histiocytes:\n    + [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html), [CD163](https://www.pathologyoutlines.com/topic/cdmarkerscd163.html) ([Hum Pathol 2018;81:157](30031096))* Multinucleated giant cells:\n      + [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html), [cathepsin K](https://www.pathologyoutlines.com/topic/stainscathepsink.html) ([Hum Pathol 2019;85:168](30447297))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-24",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Negative stains",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#negativestains385464",
    "clean_content": "Negative stains\n\n* Neoplastic cells:\n  + [CD68](https://www.pathologyoutlines.com/topic/cdmarkerscd68.html), [CD163](https://www.pathologyoutlines.com/topic/cdmarkerscd163.html), [S100](https://www.pathologyoutlines.com/topic/stainss100.html), [CD45](https://www.pathologyoutlines.com/topic/cdmarkerscd45.html)* Histiocytes and multinucleated giant cells:\n    + [Cytokeratins](https://www.pathologyoutlines.com/topic/stainsckgeneral.html), [p53](https://www.pathologyoutlines.com/topic/stainsp53.html)"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-25",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Electron microscopy description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#electronmicroscopydescription385465",
    "clean_content": "Electron microscopy description\n\n* Neoplastic cells: abundant mitochondria, no microvilli or desmosomes ([J Korean Med Sci 2005;20:516](15953882))* Multinucleated osteoclast-like giant cells: multiple nuclei with rim of chromatin; abundant mitochondria; free ribosomes; dilated, empty, rough endoplasmic reticulum cisternae ([J Korean Med Sci 2005;20:516](15953882))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-26",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Electron microscopy images",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#electronmicroscopyimages385466",
    "clean_content": "Electron microscopy images\n\nImages hosted on other servers:  \n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc03.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782216/figure/F4/)\n\nNeoplastic cell\n\n[![](https://www.pathologyoutlines.com/thumb/pancreasosteoclasticpmc04.jpg)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782216/figure/F5/)\n\nGiant cell"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-27",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#molecularcytogeneticsdescription385467",
    "clean_content": "Molecular / cytogenetics description\n\n* Overlaps with the genetic profile of conventional [ductal adenocarcinoma](https://www.pathologyoutlines.com/topic/pancreasductal.html), with the most common mutated genes being *KRAS, TP53, CDKN2A* and *SMAD4* ([J Pathol 2017;243:148](28722124))* *GLI3*, a gene belonging to the hedgehog signaling pathway, may be found mutated in this tumor* The same mutation (290â€‰Mâ€‰>â€‰L) affecting the gene *SERPINA3* has been documented in 25% of cases in a whole exome sequencing analysis ([J Pathol 2017;243:148](28722124))"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-28",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#samplepathologyreport385468",
    "clean_content": "Sample pathology report\n\n* Pancreas, pancreatectomy:\n  + Pancreatic undifferentiated carcinoma with osteoclast-like giant cells (see synoptic report)"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-29",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#differentialdiagnosis385469",
    "clean_content": "Differential diagnosis\n\n* [Undifferentiated / anaplastic carcinoma of the pancreas](https://www.pathologyoutlines.com/topic/pancreasundifferentiated.html):\n  + Absence of osteoclast-like giant cells* [Paraduodenal (groove) pancreatitis](https://www.pathologyoutlines.com/topic/pancreaschronic.html):\n    + Multinucleated giant cells may be abundant but neoplastic cells are lacking ([Cytopathology 2015;26:122](24650015))* [Melanoma](https://www.pathologyoutlines.com/topic/skintumormelanocyticmelanoma.html):\n      + Contains melanin pigment instead of or in addition to hemosiderin+ [S100](https://www.pathologyoutlines.com/topic/stainss100.html)+"
  },
  {
    "id": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt-30",
    "source_document": "undifferentiated-carcinoma-with-osteoclast-like-giant-cells_42212_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/pancreasosteoclastic.html#additionalreferences385474",
    "clean_content": "Additional references\n\n* [WHO Classification of Tumours Editorial Board: Digestive System Tumours, 5th Edition, 2019](https://www.amazon.com/exec/obidos/ASIN/9283244990/pathologyoutl-20)"
  }
]